Mario Sznol, MD
Professor of Medicine (Medical Oncology)Cards
About
Research
Overview
Dr. Sznol has an international reputation in cancer drug development. Dr. Sznol's expertise and experience is in cancer immunotherapy, drug development for cancer, and treatment of patients with melanoma and renal cell carcinoma. He is working to expand the opportunities for clinical trials at the Yale Cancer Center, particularly those focusing on immunotherapy and novel agents.
Medical Research Interests
Clinical Care
Overview
Mario Sznol, MD, is a medical oncologist at Yale Medicine and the co-director of the Cancer Immunology Program at Yale Cancer Center. He sees patients with melanoma (a type of skin cancer), or kidney cancers.
Dr. Sznol became interested in melanoma and kidney cancers early in his career following his research interest in immunotherapies. Those immunotherapies were particularly effective for melanoma and kidney cancer patients.
As a clinician, Dr. Sznol aims to be honest and straightforward with his patients. “We have a very frank discussion with our patients about the disease, what to expect, and all the options for treatment if treatment is indicated.” From there, he engages his team to help patients schedule their treatments and feel as comfortable as possible with the experience. “One of the best ways to make sure our patients and their families feel most comfortable is to provide reassurance that our team at Smilow is available to provide support and help whenever necessary.”
Dr. Sznol believes that his team’s expertise and genuine care for patients, as well as the easy access to great medical colleagues, is what sets him apart as a doctor. “We get excited when we can help people and return them back to their normal lives,” he says.
In addition to seeing patients, Dr. Sznol conducts research on new treatments for melanoma and kidney cancers with a major focus on immunotherapies. He is also a professor of medicine (medical oncology) at Yale School of Medicine.
Clinical Specialties
Fact Sheets
Kidney Cancer
Learn More on Yale MedicineSentinel Lymph Node Biopsy
Learn More on Yale MedicineMelanoma
Learn More on Yale MedicineMetastatic Cancer
Learn More on Yale Medicine
Board Certifications
Medical Oncology
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 1987
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 1985
Yale Medicine News
News & Links
News
- October 31, 2024
YCC Publications 2024
- August 30, 2024
Yale Research Highlights Unmet Needs for Patients With Melanoma Who Progress or Relapse After Immunotherapy Treatment
- May 10, 2024Source: Yale Medicine
How Immunotherapy Can Treat Cancer and Other Diseases: 8 Things to Know
- January 04, 2024
Immunotherapy for Metastatic Cancer on the Rise, Even Near End of Life